Alvotech meeting investors and participates in fireside chat at barclays 27th global healthcare conference in miami, florida

Alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in barclays 27th annual global healthcare conference, which will be held in miami, florida on march 11-13, 2025. robert wessman, founder, chairman and ceo and members of the management team will host one-on-one meetings. alvotech will also be participating in a fireside chat on wednesday, march 12, 2025, at 9:30-9:55 am edt (13:30-13:55 gmt).
ALVO Ratings Summary
ALVO Quant Ranking